The Clinical Outcome of COVID-19 Infection on Chronic Diabetic Complications Patients
Downloads
Introduction: COVID-19 is an infectious disease resulting from the SARS-CoV-2 virus. The virus targets the respiratory system and leads to a significant number of fatalities worldwide. Consequently, it was officially classified as a pandemic in 2020. The Covid varians is now being monitored by the World Health Organization. Diabetes mellitus is one of the disorders that might deteriorate following an infection. Diabetes mellitus and its associated comorbidities continue to pose a significant health challenge in Indonesia, while it is also a focus of concern of the Sustainable Development Goals (SDGs). The study was aimed to assess the risks and outcomes associated with COVID-19 infection and the long-term consequences of diabetes mellitus.
Methods: This was a descriptive study using a retrospective design. Research data were taken from the medical records of patients confirmed positive for COVID-19 infection and also had chronic complications of diabetes mellitus who were treated at Dr Soetomo General Academic Hospital, Surabaya, Indonesia in 2021. There were 156 patients who met the criteria of this research.
Results: There were 156 patients (97 males, 59 females). The average age of the patients was 58, while most of the patients (84%) died and the rest of the patients (16%) survived. Most of the patients with fatality (55.8%) were those with critical severity level and complications of microangiopathy, while the patients who survived (10.3%) were those with moderate severity level and complications of microangiopathy.
Conclusion: COVID-19 patients with diabetes and comorbidities had a higher mortality rate than those who recovered, while most of the patients with fatality were those with significant COVID-19 and diabetic microangiopathy complications.
Amini MA, et al. 2022. The association of COVID-19 and Reactive Oxygen Species Modulator 1 (ROMO1) with oxidative stress. Chonnam Medical Journal 58(1):1. https://doi.org/10.4068/CMJ.2022.58.1.1.
Arfijanto MV, et al. 2023. Duration of SARS-CoV-2 RNA shedding is significantly influenced by disease severity, bilateral pulmonary infiltrates, antibiotic treatment, and diabetic status: consideration for isolation period. Pathophysiology 30(2):186–198. https://doi.org/10.3390/PATHOPHYSIOLOGY30020016.
Bhatti JS, et al. 2022. Oxidative stress in the pathophysiology of type 2 diabetes and related complications: Current therapeutics strategies and future perspectives. Free Radical Biology and Medicine 184:114–134. https://doi.org/10.1016/J.FREERADBIOMED.2022.03.019.
CDC. 2023. What is diabetes?. CDC. Available at: https://www.cdc.gov/diabetes/basics/diabetes.html. Accessed on 5 September 2023.
Ciarambino T, et al. 2022. Influence of gender in diabetes mellitus and its complication. International Journal of Molecular Sciences 23(16):8850. https://doi.org/10.3390/IJMS23168850.
Dewi GAAIK, et al. 2020. View of risk factors for lower extremity amputation in diabetic foot ulcer patients: a case-control study. JUXTA: Jurnal Ilmiah Mahasiswa Kedokteran Universitas Airlangga. https://e-journal.unair.ac.id/JUXTA/article/view/19817/11919.
Elsayed NA, et al. 2023. 2. Classification and diagnosis of diabetes: standards of care in diabetes”2023. Diabetes Care, 46(Suppl 1):S19. https://doi.org/10.2337/DC23-S002.
Farmaki P, et al. 2020. Complications of the Type 2 diabetes mellitus. Perspective Current Cardiology Reviews 16(4):249. https://doi.org/10.7326/0003-4819-152-5-201003020-01003.
Fatmaningrum DA, Anis W, Laksana MAC. 2022. The impact of the Covid-19 pandemic on maternal mortality attributes. Indonesian Journal of Health Administration (Jurnal Administrasi Kesehatan Indonesia) 10(1):70–78. doi: 10.20473/jaki.v10i1.2022.70-78.
Guo W, et al. 2020. Diabetes is a risk factor for the progression and prognosis of COVID-19. Diabetes Metab Res Rev 36(7):e3319. doi: 10.1002/dmrr.3319.
Hendyatama TH and Mardiana N. 2020. Calculation of drug dosage in chronic kidney disease. Current Internal Medicine Research and Practice Surabaya Journal 1(1):21–24. https://doi.org/10.20473/CIMRJ.V1I1.16894.
Hidayat B, et al. 2022. Direct medical cost of type 2 diabetes mellitus and its associated complications in Indonesia. Value in Health Regional Issues 28:82–89. https://doi.org/10.1016/J.VHRI.2021.04.006.
Jain U. 2020. Effect of COVID-19 on the organs. Cureus 12(8). https://doi.org/10.7759/CUREUS.9540.
Jose RJ and Manuel A. 2020. COVID-19 cytokine storm: the interplay between inflammation and coagulation. The Lancet Respiratory Medicine 8(6):e46–e47. https://doi.org/10.1016/S2213-2600(20)30216-2.
Kharroubi SA and Diab-El-Harake M. 2022. Sex-differences in COVID-19 diagnosis, risk factors and disease comorbidities: A large US-based cohort study. Frontiers in Public Health, 10. https://doi.org/10.3389/FPUBH.2022.1029190.
Kirkman MS, et al. 2012. Diabetes in older adults. Diabetes Care 35(12):2650. https://doi.org/10.2337/DC12-1801.
Klebanoff MA and Snowden JM. 2018. Historical (retrospective) cohort studies and other epidemiologic study designs in perinatal research. American Journal of Obstetrics and Gynecology 219(5):447–450. https://doi.org/10.1016/j.ajog.2018.08.044.
Mao W, Yip CMW, Chen W. 2019. Complications of diabetes in China: Health system and economic implications. BMC Public Health 19(1):1–11. https://doi.org/10.1186/S12889-019-6569-8/TABLES/2.
Nanayakkara N, et al. 2021. Impact of age at type 2 diabetes mellitus diagnosis on mortality and vascular complications: systematic review and meta-analyses. Diabetologia 64(2):275–287. https://doi.org/10.1007/S00125-020-05319-W/FIGURES/3.
Neumiller JJ, et al. 2022. The Epidemiology of diabetic kidney disease. Kidney and Dialysis 2(3):433-442. https://doi.org/10.3390/KIDNEYDIAL2030038.
NIH. 2023. Clinical Spectrum | COVID-19 Treatment Guidelines, NIH. Available at https://www.covid19treatmentguidelines.nih.gov/overview/clinical-spectrum/. Accessed on 9 September 2023.
Ong C. 2022. Characteristic of chronic complications in type 2 diabetic patient based on asian perspective. Current Internal Medicine Research and Practice Surabaya Journal 3(1):13-15. https://e-journal.unair.ac.id/CIMRJ/article/view/31412/16991.
Qi S, et al. 2021. Sex differences in the immune response to acute COVID-19 respiratory tract infection. Biology of Sex Differences 12. https://doi.org/10.1186/s13293-021-00410-2.
Sulistyowati ES, Muninggar SS, Silalahi V. 2021. Risk factors of Covid-19 confirmed died patients in Dr. Kariadi Hospital: a retrospective study. Indonesian Journal of Tropical and Infectious Disease 9(1):1–8. https://doi.org/10.20473/ijtid.v9i1.22609.
Sutadji JT, et al. 2023. Risk factors of Chronic Kidney Disease (CKD) in type 2 Diabetes Mellitus (DM) patients at Dr. Soetomo General Academic Hospital, Surabaya. Jurnal Ilmiah Mahasiswa Kedokteran Universitas Airlangga 14(1):12-16. https://e-journal.unair.ac.id/JUXTA/article/view/38787/23750.
Vollbracht C and Kraft K. 2022. Oxidative stress and hyper-inflammation as major drivers of severe COVID-19 and long COVID: implications for the benefit of high-dose intravenous vitamin C. Frontiers in Pharmacology 13:1. Available at: https://doi.org/10.3389/FPHAR.2022.899198.
WHO. 2020. Statement – older people are at highest risk from COVID-19, but all must act to prevent community spread, WHO. Available at https://www.who.int/europe/news/item/03-04-2020-statement-older-people-are-at-highest-risk-from-covid-19-but-all-must-act-to-prevent-community-spread. Accessed on 10 September 2023.
WHO. 2023a. Diabetes, WHO. Available at https://www.who.int/news-room/fact-sheets/detail/diabetes. Accessed on 8 September 2023.
WHO. 2023b. Tracking SARS-CoV-2 variants, WHO. Available at https://www.who.int/activities/tracking-SARS-CoV-2-variants. Accessed on 5 September 2023.
Zhang J, Zhang J, Tao Z. 2022. Effect of comorbid diabetes on clinical characteristics of COVID-19 patients infected by the wild-type or delta variant of SARS-CoV-2. Frontiers in Endocrinology 13. https://doi.org/10.3389/FENDO.2022.861443.
Copyright (c) 2024 erlisa pramodya wardani, Tri Pudy Asmarawati, Isnin Anang Marhana, Hermina Novida
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Copyright (c) Author
1. The journal allows the author to hold the copyright of the article without restrictions.
2. The journal allows the author(s) to retain publishing rights without restrictions.
3. The formal legal aspect of journal publication accessibility refers to Creative Commons Atribution-Share Alike 4.0 (CC BY-SA).
